Suchen
Genenta Science SPA
GNTAZur Watchlist hinzufügen
0.710USD
-0.045-5.96%
Handelsschluss 10-08 16:00（ET）
16.64MMarktkapitalisierung
VerlustKGV TTM
Vorbörsliches Trading 04:20 (ET)0.742USD+0.032+4.51%
Vorbörsliches Trading 04:20 (ET)Über Genenta Science SPA Unternehmen
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Genenta Science SPA Profil
BörsenkürzelGNTA
Name des UnternehmensGenenta Science SPA
IPO-datumDec 15, 2021
CEOParacchi (Pierluigi)
Anzahl der mitarbeiter13
WertpapierartDepository Receipt
GeschäftsjahresendeDec 15
AddresseVia Olgettina 58
StadtMILANO
BörseNASDAQ OMX - NASDAQ BASIC
LandItaly
Postleitzahl20132
Telefon
Websitehttps://www.genenta.com/
BörsenkürzelGNTA
IPO-datumDec 15, 2021
CEOParacchi (Pierluigi)
Führungskräfte von Genenta Science SPA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chief Executive Officer, Chairman of the Board and General Manager
Chief Executive Officer, Chairman of the Board and General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Vice President - Finance and Group Integration
Vice President - Finance and Group Integration
--
--
Dr. Francesco Galimi, M.D., Ph.D.
Dr. Francesco Galimi, M.D., Ph.D.
Non-Independent Director, Acting Chief Medical Officer and Head of Development
Non-Independent Director, Acting Chief Medical Officer and Head of Development
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chief Executive Officer, Chairman of the Board and General Manager
Chief Executive Officer, Chairman of the Board and General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Genenta Science SPA?
Die fünf größten Anteilseigner von Genenta Science SPA sind: Mr. Pierluigi Paracchi
Wie viele Institutionen halten Anteile an Genenta Science SPA (GNTA)?
Mit Stand vom 2026Q1 halten 24 Institutionen Anteile an Genenta Science SPA, mit einem Gesamtmarktwert von etwa 3.34M, was 14.15% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 1015532.00 gestiegen.